Background: Osteoporosis that is characterized by low bone mass and strength which in turn increases the risk of developing fractures. It is sometimes referred to as silent disease due to its asymptomatic obsolescence until first fracture occurs. Current study was conducted to study the effect of vitamin D using a clinical dose of this vitamin given twice a day to osteoporosis patients in the city of Tikrit and from both sexes who visit Dr. Abdulrazzaq Mahmood Al-Khattabi's clinic and Salahuddin General Hospital. Methods: The research involved 86 subjects (26 males and 60 females) aged between (25-79) years to study the clinical effect of vitamin D on them. In addition, 36 subjects (20 males and 16 females) aged between (25-79 years) of healthy persons were recruited as a control group. The research subjects were divided into two groups; the first of which included the age group (25-54) years while the second included the age group (65-79) years. They were each given a dose of (5000IU) of vitamin D and a dose of (500mg) of calcium twice a day, in the morning and in the evening, for three months with follow-up of subjects periodically each month to observe the changes by measuring a number of biochemical parameters represented in the examination of bone density, vitamin D, serum calcium, serum alkaline phosphatase and C-Reactive Protein. Patients with rheumatism, taking cortisone or any item containing it, and pregnant women were excluded from this research. Results: The results shown a significant increase in bone density in both groups and for both sexes as well as higher levels of vitamin D and calcium compared to the control group. However, the results showed a significant decrease in alkaline phosphatase effectiveness in both groups. Moreover, there was a decrease in the level of C-Reactive Protein in males of both groups and in females from the first group. No significant differences were recorded in the second group compared to the control group.
Introduction
Health of bones is critical because of the vital functions of these organs represented by providing support, protection, movement, generation of blood cells as well as the storage of salts and fat [1] . It is recognized that bones, like other organs in the body, have their cells prone to regeneration and replacement throughout life. Thus, they are also at risk of certain diseases such as osteoporosis that is characterized by low bone mass and strength which in turn increases the risk of developing fractures. It is sometimes referred to as silent disease due to its asymptomatic obsolescence until first fracture occurs [2] .
Vitamin D deficiency is characterized as a global dilemma since it is a major factor in various immune functions along with its role in development of the skeleton and muscles [3] . The countries of the world vary in the definition of vitamin D deficiency and, therefore, in determining the concentration that puts individuals at risk of deficiency. Some consider the concentration of less than (30nmol/l) as a deficiency of this vitamin [4] and others consider the concentration of (50nmol/l) as a measure of deficiency as it is the lowest acceptable value for vitamin D concentration in the serum [4, 5] . As for that recommended by the National Academy of Medicine of the United States of America in 1997 diet system which was deliberately renewed in 2016 and known as the Dietary Reference Intake (DRI), the intake should be (600IU) equivalent to (15micrograms) daily for children and (4000IU) equivalent to (100micrograms) for adults, to avoid risk of taking overdose as well as knowing the daily dose of the vitamin needed to avoid risk of deficiency [6] .
Materials and Methods
The research was conducted on samples from both sexes of Osteoporosis patients who visit Dr. Abdulrazzaq Mahmoud Al-Khattabi's clinic and Salahuddin General Hospital for the period from the beginning of August 2018 to the end of April 2019. Table (1) showed the experimental design of the research regarding the division of samples and the treatment program with vitamin D and calcium. A number of biochemical parameters such as bone density, vitamin D, calcium, alkaline phosphatase (ALP) and Creactive protein (CRP) were measured for all participants as follows:
Bone mineral density measurement:
The Dual-energy X-ray absorptiometry (DEXA) test has been adopted for this purpose in spine and femoral bones by GE-Prodigy device, which takes into account the low radiation dose during short time photo scanning, low color distortion and image accuracy.Then, the results of the photo scan for bones of the study subjects were used to calculate Bone Mineral Density (BMD) according to the following formula:
T Degree=
Estimation of serum vitamin D and (CRP) concentrations:
Kits were used for these tests, and its work was based on the method of competitive immune detection from IchromaTM Company.
Estimation of serum calcium concentration:
A kit was used for this test; concentration was estimated following the principle described by using a special and equipped analysis kit from the French company Biolabo.
Estimating effectiveness of serum alkaline phosphatase enzyme:
The spectral method was relied on for estimating the effectiveness of ALP enzyme in serum using a kit according to the Kind and King method [7] . Effectiveness was estimated following the principle described by using a special and equipped analysis kit from the French company Biolabo.
Results were statistically analyzed using SPSS depending on Analysis of Variance ANOVA and Duncan multiple range tests. The significant differences were calculated at a probability level (P<0.05) for comparison between research groups.
Results
This research was planned as a therapeutic attempt for osteoporosis in males and females in two age groups through treatment with a dose of vitamin D 3 within the limits of clinical use and enhanced with a dose of calcium, and then a follow up of subjects through periodic monitoring of five biochemical parameters closely related to the disease represented by examining bone mineral density and vitamin D and calcium concentrations as well as ALP activity and serum protein C concentration. Data from current study revealed that:
First experimental group 1. Bone mineral density
The results obtained showed an increase in bone mineral density in males and females after treatment compared to that before treatment according to the experimental program mentioned in Table ( 1) . This was reinforced by statistical analysis which showed significant differences at the probability level (P˂0.05) as well as statistical differences when compared to the control group as shown in Table ( 2) and Figure ( 
Serum Vitamin D 3 concentration
The results indicated a significant increase in the concentration of vitamin D 3 in serum of males and females after treatment compared to that before treatment based on the experimental design mentioned in Table (1) . After the statistical analysis of these results, significant differences were evident at the level of probability (P˂0.05) as well as statistical differences between them over one, two and three months and between the control group as shown in Table ( 3) and Figure  ( 
Serum calcium concentration
By reviewing the results in Table ( 4) , the increase in Calcium concentration was evident and for both sexes after treatment compared to that before treatment based on the experimental design adopted in this research and shown in Table (1) . When analyzing these results statistically, significant differences were evident over one, two and three months at the probability level (P˂0.05) as well as statistical differences when compared with control group (Figure 4 ). 
Serum ALP activity
Statistical analysis of the results shown in Table ( 5) revealed a significant decrease at the level of probability (P˂0.05) in the effectiveness of ALP enzyme in serum of males and females after treatment compared with that before treatment according to the experimental program mentioned in Table ( 1) over one, two and three months as well as statistical differences when compared with the control group ( Figure 5 ). 
Serum CRP concentration
The results of Table (6) indicated that there was a significant decrease in the concentration of reactive protein C in serum for both sexes after treatment compared with that before treatment according to the experimental design shown in Table ( 1) . The results of statistical analysis were reinforced by statistical differences over one, two and three months as well as significant differences when compared with the control group ( Figure 6 ). 
Second experimental group 1. Bone mineral density
The results obtained showed an increase in the bone mineral density of males and females after treatment compared with pre-treatment according to the experimental program mentioned in Table ( 1) . This was reinforced by statistical analysis which showed significant differences at the probability level (P˂0.05) as well as statistical differences when compared with control group as shown in Table (7) and Figure (7) . 
Serum Vitamin D 3 concentration
The results indicated a significant increase in the concentration of vitamin D 3 in serum of males and females after treatment compared to before treatment based on the experimental design mentioned in Table (1) . As well as statistical differences between them over one, two and three months and between the control group as shown in Table (8) and Figure  ( 
Serum calcium concentration
By reviewing the results in Table (9), there was an increase in calcium concentration for both sexes after treatment compared to before treatment based on the experimental design adopted in this research and shown in Table (1) and, when analyzing these results, statistically significant differences were evident over one, two and three months at the probability level (P˂0.05), as well as statistical differences when compared with the control group, as shown in Figure ( 
Serum ALP activity
Statistical analysis of the results shown in Table ( 10) showed a significant decrease at the level of probability (P˂0.05) in the effectiveness of serum ALP enzyme in males and females after treatment compared with that before treatment according to the experimental program mentioned in Table ( 1) over one, two and three months as well as statistical differences when compared with the control group ( Figure 10 ). 
Serum CRP concentration
The results of Table (11) indicated that there was a significant decrease in the concentration of reactive protein C in serum for both sexes after treatment compared to that before treatment according to the experimental design shown in Table ( 1) . The results of statistical analysis were reinforced by statistical differences over one, two and three months as well as significant differences when compared with the control group (Figure 11 ). 
Discussion
Despite the important scientific progress that has been achieved in studies that highlighted the issue of osteoarthritis, its causes and consequences, it remains a source of concern and a global dilemma.
Through the review of scientific researches in this regard, it was noted that some of them addressed the therapeutic aspect and varying doses of vitamin D 3 which was high and low compared to the recommended dose. When the focus of the research in the scientific literature is on indicators or biochemical parameters that can be adopted in combination to follow the treatment, it was observed of limitation if not absent.
Bone mineral density
It is a medical term for the amount of minerals per square centimeter of bone tissue and is often used in clinical medicine as an indirect indicator of Osteoporosis and risk of fractures, although it does not represent the actual physical density of bone calculated on the basis of its mass relative to its size [8] . It is known that there is a statistical relationship between low bone density and a greater risk of fracture, which is considered a public health problem, especially in elderly women and especially if the fracture is of leg or pelvis which causes difficulty in daily life and in conducting life requirements as well as the large therapeutic cost [9] .
The variation in physiological status between males and females will lead to variation in the rate of bone density and changes depending on the health status and, since the muscular effort is accompanied by an increase in bone density and is generally greater in men than in women, so their bone density is higher. In addition, women suffer from a decrease in the level of estrogen-known to affect bone safety-as they age, particularly after menopause, in addition to being less exposed to sunlight, especially in conservative societies due to social norms. Moreover, cases of multiple pregnancy and lactation if followed by unhealthy diet i.e. Osteoporosis based on what was referred to what mentioned above in the increasing incidence in women more than men at an early age [10] .
Numerous studies have confirmed that daily vitamin D 3 and calcium treatment significantly reduce the incidence of fractures compared to control group as well as preventing muscle weakness and consequent avoidance of falls and fractures. This increases bone mineral density and reduces the speed of decomposition or resorption [11] as well as that treatment with a high dose of D 3 for one time yearly may have harmful side effects as well as their ineffectiveness in reducing Osteoporosis and thus the risk of fractures [12] .
Most studies confirmed that age obsolescence is one of the most important indicators of Osteoporosis through its reverse or negative association so to speak with the mineral density of bones.
This concept has a statistical significance common among those studies, because old age accelerates the reduction of bone mineral density and thus fragility, so it is obligatory to reach the maximum bone mineral mass at the age limit of 35 years [13] , especially in women because they are more likely to have lower average bone density. These lower average densities are (10% higher than in men and all ages, and more than 40-50% of peak bone mass in post-menopause [14] .
In addition, calcium and phosphorus deficiency may reduce the formation of hydroxyapatite crystals in women suffering from Osteoporosis. Therapeutic drugs stimulate its construction, since its increased effectiveness in the blood is relatively well associated with the increase in bone mineral density, except in the case of postmenopausal women making it an important sign of Osteoporosis [15, 16] .
Serum Vitamin D 3 concentration
The serum D 3 concentration is closely related to bone mineral density, regulating bone differentiation (bone growth and development), as well as a key regulator of calcium rebalancing. Its effectiveness is to maintain calcium levels within normal limits by enhancing its absorption from the intestine, reducing its loss in urine by increasing the reabsorption in the kidneys, as well as maintaining the balance of phosphate level in bones and blood and thus maintain bone health, noting that the level of calcium significantly decreases in the elderly, especially over 60 years and this imbalance is mainly due to low serum D 3 level [17] .
The results of a study indicated that the adoption of a dose of 5000IU of vitamin D 3 per day for (12) months significantly increased the concentration of this vitamin without adverse effects. This dose for adults and older people with D 3 deficiency confirms that the level of (75nmol/l and; therefore, higher than the target to be achieved with the assurance that there were no side effects [18] . In another study on females older than 65 years, they were divided into two groups in which the first received a dose of 300,000IU of D 3 once every three months while the second received a dose of 1000IU of D 3 . The results showed a significant increase in the concentration of vitamin D 3 for both groups, but it was higher in the first group where the level of D 3 in the serum increased by 55% against 20% in the second group, which indicated that the dose received by the first group once every three months was more effective than the daily dose over 6 months. Aalthough the study did not determine the optimal dose of D 3 at all, it recommended that the most useful and effective concentration starts from 75nmol/l and is specifically between 90-100nmol/l provided that the effects of these doses are monitored in future studies [19] .
Serum calcium concentration
It is a well-known fact that Osteoporosis is commonly associated with poor or lack of absorption or increased loss of calcium which in turn results in decreased concentration and imbalance in the blood and bone store, thus influencing its role in bone construction and maintenance [22] .
Most sources have dealt with studies of women samples. In one study, researchers found that taking a dose of 250 or 500mg of calcium a day effectively prevented Osteoporosis in women before and after menopause. The study was conducted on Japanese women within the age group (50-70) years, and medical examinations on the periodic follow-up of those cases were conducted three times over two years to assess the mineral density of lumbar and cervical spine [23] .
Calcium is regarded as a necessary chemical element for living organisms. It is an important regulator of many cellular functions through the multiple roles played by Ca +2 inside and outside cells, being the most abundant metal in the body. It is involved in the structure of skeleton and comprises the ratio of about 1.5-2.2% of total body mass, of which 99% is stored in bones and 1% is present in blood and extracellular fluid [24] . Although serum calcium level or concentration is a relatively weak indicator of traits, it does not accurately indicate bone resorption in Osteoporosis patients [25, 26] . However, the National Organisation for patients with Osteoporosis recommends the need to take 1200mg of calcium as well as 800-1000IU of vitamin D daily for those over the age of 50 years, as it confirms the preference to get calcium from food sources and not supplements and; therefore, healthy bones are the result of a healthy calcium-rich diet [27] .
Serum ALP activity
Because there are many causes that contribute to increased serum ALP activity, its efficacy is an indicator and not a catalyst in detecting Osteoporosis [28] . Bone cells are rich in ALP as well as linked to the plasma membrane of the liver, intestines and placenta. This makes it a participant in increasing its overall blood concentration [29] . ALP efficacy in serum samples of both males and females has been adopted as a tool for detecting Osteoporosis as a good indicator in cases of bone diseases such as Osteoporosis as well as liver disease and biliary obstruction [30] . A positive correlation between the effectiveness of bone-specific ALP and the speed of bone degradation was observed in a study in Hawaii, which called for a valuable marker in assessing the risk of fracture [31] .
ALP is a membrane-bound enzyme, with a half-life of about 7 days. Its sources vary and work with different degrees of enzymatic activity depending on the needs of the tissue or organ where it is present such as liver, bones, intestines, kidneys and placenta [32] . Bone phosphatase contributes to ossification through the deposition of minerals, especially calcium phosphate. Any disruption in the speed of deposition of calcium salts in the bone results in a change in the effectiveness of this enzyme in the blood [33] .
Serum CRP concentration
Although serum CRP concentration may not be a primary predictor of low bone mineral density or decomposition, its elevation is a secondary indicator of continued decomposition or Osteoporosis associated with aging [34] . This explained the rise in serum levels of all samples of current study and then decreased after treatment with vitamin D 3 enhanced by calcium. This decline was synchronized with the high level of bone mineral density, which is confirmed by these results. These results were confirmed by a study which included males and females with an average age 46 years. Their results indicated a statistically significant inverse relationship between vitamin D at less than 21ng/mol and high concentration of CRP in the serum and when treated with a high dose of vitamin D, the level of CRP decreases. The study also concluded that the role of vitamin D supplements to reduce inflammation is useful only in those with a lack of concentration in the serum. The serum CRP concentration did not decrease in people who had a vitamin level higher than 50ng/ml [35] .
Inflammation may adversely affect other aspects of bone health beyond mineral density to fractures [36] , as there is an inverse relationship between the CRP level and the strength index of the femoral neck as well [37] . In addition, there is an association of CRP with structural changes in spongy bone trabeculae in older men [38] .
There are many ways in which vitamin D can affect the immune system and thus explain the observed association of a change in serum CRP concentration, including that with respect to vitamin D receptors that are on white blood cells as well as single and auxiliary T cells [39] and the mechanism of vitamin conversion to the active form and associated efficacy of the immune cells to inhibit the signs of inflammation. This means that the relationship between the concentration of CRP and vitamin D in the serum is inverse because low vitamin D leads to rapid decomposition and Osteoporosis which in turn raises CRP level in serum and vice versa [40] .
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